Resveratrol-Mediated Inhibition of Ang II-Induced Akt Phosphorylation in VSMC – Is it an Antioxidant Activity?

SCHREINER, C. E.; KUMERZ, M.; GESSLBAUER, J.; ATANASOV, A. G.; HEISS, E. H.; ERKER, T.; DIRSCH, V. M.

doi:10.3797/scipharm.oephg.21.PO-43

Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).

Abstract

16 April 2009

1 Page

Resveratrol-Mediated Inhibition of Ang II-Induced Akt Phosphorylation in VSMC – Is it an Antioxidant Activity?

and

University of Vienna, Department of Pharmacognosy, Althanst. 14, 1090 Vienna, Austria

University of Vienna, Department Department of Pharmaceutical Chemistry, Althanstr. 14, 1090 Vienna, Austria

Author to whom correspondence should be addressed.

Sci. Pharm.2009, 77(7), 242;https://doi.org/10.3797/scipharm.oephg.21.PO-43

Version Notes

Order Reprints

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

It was previously shown by us that resveratrol (RV) is able to inhibit the angiotensin (Ang) II-induced phosphorylation of the protein kinase Akt in vascular smooth muscle cells (VSMC).[...]

Article Metrics

Citations

Article Access Statistics

Journal Statistics

Multiple requests from the same IP address are counted as one view.

A Norepinephrine Transporter Assay for the Screening of Natural Products

Distinct Anti-Migratory Effects of Resveratrol on EGF- versus PDGF-Stimulated Vascular Smooth Muscle Cells